Invention Grant
- Patent Title: PD-1 antibodies
-
Application No.: US16073942Application Date: 2017-01-23
-
Publication No.: US10913801B2Publication Date: 2021-02-09
- Inventor: Hemanta Baruah , Cheng Chen , Xiaolin Liu , Andy Tsun , De-Chao Michael Yu
- Applicant: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Applicant Address: CN Suzhou
- Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Current Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD
- Current Assignee Address: CN Suzhou
- Agency: Ladas & Parry LLP
- Priority: WOPCT/CN2016/073169 20160202
- International Application: PCT/CN2017/072190 WO 20170123
- International Announcement: WO2017/133540 WO 20170810
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K39/395 ; C12N5/10 ; A61K39/00
Abstract:
The present invention relates to antibodies that bind human programmed cell death 1 (PD-1), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
Public/Granted literature
- US20190040149A1 PD-1 ANTIBODIES Public/Granted day:2019-02-07
Information query
